Priti Tewari, M.D.
Department of Pediatrics, Division of Pediatrics
Present Title & Affiliation
Primary Appointment
Section Chief, Pediatrics Stem Cell Transplantation & Cell Therapy, Pediatrics Patient Care, The University of Texas MD Anderson Cancer Center, Houston, TX
Professor, Pediatrics Patient Care, The University of Texas MD Anderson Cancer Center, Houston, Texas
Pediatric Stem Cell Transplantation Service Medical Director, Pediatrics Patient Care, The University of Texas MD Anderson Cancer Center, Houston, TX
Professor (Joint appointment), Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
Fellowship Program Director, Pediatrics Patient Care - Hematology Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Fellowship Program Director, Pediatrics Patient Care, The University of Texas MD Anderson Cancer Center, Houston, TX
Fellowship Program, Program Evaluation Committee, Chair, Pediatric Hematology-Oncology, Pediatrics Patient Care, The University of Texas MD Anderson Cancer Center, Houston, TX
Research Interests
Supportive Care in Pediatric Stem Cell Transplantation
Graft-Versus Host Disease
Education & Training
Degree-Granting Education
| 2003 | Ross University School of Medicine, Roseau, US, MD |
| 1998 | State University of New York at Stony Brook, Stony Brook, New York, US, BS in Biochemistry |
Postgraduate Training
| 2023-2024 | Cohort 11 of APPD LEAD Graduate, Association of Pediatric Program Directors LEAD Program, Chicago, Illinois |
| 2020-2021 | Health Educators Fellowship Graduate, University of Texas, Houston, Texas |
| 2009-2011 | Clinical Fellowship, Pediatric Bone Marrow Transplant, Duke University Medical Center, Durham, North Carolina |
| 2006-2009 | Clinical Fellowship, Pediatric Hematology/Oncology, Albert Einstein College of Medicine - Children's Hospital at Montefiore, Bronx, New York |
| 2003-2006 | Clinical Residency, Pediatrics, State University of New York, Brooklyn, New York |
Licenses & Certifications
| 2012 | Texas Medical Board |
| 2011 | Pediatric Hematology/Oncology |
| 2009 | Pediatrics |
| 2009 | Medical |
| 2007 | Medical |
Experience & Service
Faculty Academic Appointments
Associate Professor, Pediatrics Patient Care, The University of Texas MD Anderson Cancer Center, Houston, TX, 2018 - 2024
Assistant Professor, Texas Children’s Hospital - Baylor College of Medicine, Houston, TX, 2016 - 2018
Assistant Professor, Pediatrics Patient Care, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - 2016
Instructor, Pediatric Blood and Marrow Transplantation Program, Duke University Medical Center, Durham, NC, 2011 - 2012
Administrative Appointments/Responsibilities
Division Team Lead: Pediatrics Education Team, Pediatrics Patient Care, The University of Texas MD Anderson Cancer Center, Houston, TX, 2018 - 2023
Stem Cell Transplant/Cellular Therapy Education Program Lead, Texas Children’s Baylor College of Medicine, Houston, TX, 2017 - 2018
Fellowship Program Associate Director, Pediatric Hematology-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - 2016
EPIC Pediatric Stem Cell Transplant Build Physician, Pediatrics Patient Care, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - 2016
Medical Director Pediatric Stem Cell Transplantation & Cellular Therapy, Pediatrics Patient Care, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - 2016
Fellowship Program, Program Evaluation Committee, Chair, Pediatric Hematology-Oncology, Pediatrics Patient Care, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - 2016
Extramural Institutional Committee Activities
Program Mentor, The Professional Development Committee | American Society of Pediatric Hematology/Oncology, MD Anderson Cancer Center, 2025 - Present
Chair, MD Anderson Graduate Medical Education Committee (GMEC), The University of Texas MD Anderson Cancer Center, 2023 - Present
Member, Graduate Medical Education Committee (GMEC) Diversity & Disparities Committee, The University of Texas MD Anderson Cancer Center, 2022 - 2023
Vice-Chair, MD Anderson Graduate Medical Education Committee (GMEC), The University of Texas MD Anderson Cancer Center, 2022 - 2023
Chair, MD Anderson Graduate Medical Education Committee (GMEC) Well-Being Subcommittee, The University of Texas MD Anderson Cancer Center, 2021 - Present
Member, MD Anderson Cancer Center Employee Engagement Council, The University of Texas MD Anderson Cancer Center, 2021 - Present
Member, Pediatric Morbidity and Mortality Conference Review Committee, The University of Texas MD Anderson Cancer Center, 2020 - Present
Member, MD Anderson Academic Review Committee, The University of Texas MD Anderson Cancer Center, 2018 - Present
Co-Lead, MD Anderson Radiation Injury Treatment Network/National Marrow Donor Program, The University of Texas MD Anderson Cancer Center, 2018 - Present
Member, Pediatric Quality and Safety Committee, The University of Texas MD Anderson Cancer Center, 2018 - Present
Chair, Pediatric Fellowship Clinical Competency Committee, The University of Texas MD Anderson Cancer Center, 2018 - Present
Member, MD Anderson Graduate Medical Education Committee, The University of Texas MD Anderson Cancer Center, 2018 - Present
Chair, Pediatric Stem Cell Transplantation Inpatient Taskforce, The University of Texas MD Anderson Cancer Center, 2015 - Present
Chair, Inpatient Mobility Incentive Program, The University of Texas MD Anderson Cancer Center, 2015 - Present
Chair, Pediatric Fellowship Program Evaluation Committee, The University of Texas MD Anderson Cancer Center, 2014 - 2016
Member, Pediatric Quality and Safety Committee, The University of Texas MD Anderson Cancer Center, 2013 - 2016
Honors & Awards
| 2026 - Present | Division of Pediatrics “Education and Mentorship Advancement”, The University of Texas MD Anderson Cancer Center |
| 2023 | The ACGME and Gold Foundation DeWitt (Bud) C. Baldwin, Jr, The University of Texas MD Anderson Cancer Center |
| 2022 | MD Anderson Clinical Education Outstanding GME Program Director Award, The University of Texas MD Anderson Cancer Center |
| 2021 | Houstonia Magazine, Pediatric Hematology-Oncology Houston’s Top Doctor |
| 2021 | MD Anderson Faculty Educator of the Quarter, The University of Texas MD Anderson Cancer Center |
| 2020 | MD Anderson Commitment to Mentoring Award, The University of Texas MD Anderson Cancer Center |
| 2019 | MD Anderson President’s Recognition of Faculty Excellence in Education, The University of Texas MD Anderson Cancer Center |
| 2010 | Travel Grant Outstand Research, ASBMT Tandem Meeting |
| 2009 | Pediatric Research Day Fellows Award for Poster Presentation, Montefiore Medical Center |
| 2008 | Outstanding Translational Research Award, ECOG |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2024. Diversity, Equity, and Inclusion. Invited. RMHCGH Cultural Education Event with a Mental Health Focus. Houston, Texas, US.
National Presentations
- 2025. Team Me- A Successful Quality Improvement Project Physical Activity Guidelines for Children with Cancer – Time to Make a Move. Invited. The 2025 ASPHO Annual Conference. Louisville, Kentucky, US.
Formal Peers
- 2019. Radiation Injury Functional Exercise Lessons Learned. Invited. Houston, TX, US.
- 2015. Sickle Cell Disease and Stem Cell Transplantation: Is there a rainbow on the other side?. Invited. Houston, TX, US.
Grant & Contract Support
| Date: | 2022 - Present |
| Title: | Development of a Pediatric cGVHD Symptom Scale: A Cognitive Interviewing Study NIH Protocol 19-C-01 |
| Funding Source: | NIH/NCI |
| Role: | Co-PI |
| ID: | Protocol 19-C-0131 |
| Date: | 2021 - Present |
| Title: | An Open-label, Single-arm, Multicohort, Phase 2 Study to Assess the Efficacy and Safety of Tabelecleucel in Subjects with Epstein-Barr Virus-associated Diseases |
| Funding Source: | ATARA |
| Role: | Collaborator |
| ID: | 2020-0375 |
| Date: | 2020 - Present |
| Title: | Newly Diagnosed Children (Less Than 10 Years Old) with Medulloblastoma and Other Central Nervous System Embryonal Tumors: Clinical and Molecular Risk-Tailored Intensive and Compressed Induction Chemotherapy Followed by Consolidation With Either Single Cycle (Low Risk Patients) or Randomization (High Risk Patients) to Either Single-Cycle or to Three Tandem Cycles of Marrow-Ablative Chemotherapy with Autologous Hematopoietic Progenitor Cell Rescue |
| Funding Source: | Nationwide Children's Hospital |
| Role: | Collaborator |
| ID: | 2018-0840 |
| Date: | 2020 - Present |
| Title: | BMT CTN PROTOCOL 1507: Reduced Intensity Conditioning for Haploidentical Bone Marrow Transplantation in Patients with Symptomatic Sickle Cell Disease |
| Funding Source: | NIH/NCI |
| Role: | Collaborator |
| ID: | 2020-0171 |
| Date: | 2020 - Present |
| Title: | A Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients with High Risk Solid Tumors |
| Funding Source: | MDACC |
| Role: | Collaborator |
| ID: | 2020-0496 |
| Date: | 2019 - Present |
| Title: | A Phase II Pilot Trial To Estimate Survival After A Non-Total Body Irradiation (TBI) Based Conditioning Regimen In Patients Diagnosed With B-Acute Lymphoblastic Leukemia (ALL) Who Are Pre-Allogeneic Hematopoietic Cell Transplantation (HCT) Next-Generation |
| Funding Source: | Children's Hospital Los Angeles |
| Role: | Collaborator |
| ID: | 2018-0964 |
| Date: | 2019 - Present |
| Title: | Expanded Access Protocol for Providing Tabelecleucel to Patients With Epstein-Barr Virus-Associated Viremia or Malignancies for Whom There are No Appropriate Alternative Therapies |
| Funding Source: | ATARA |
| Role: | Collaborator |
| ID: | 2019-0079 |
| Date: | 2019 - Present |
| Title: | Using Game Mechanics To Improve Outcomes Among Stem Cell Transplant Survivors |
| Funding Source: | NIH/NCI |
| Role: | Collaborator |
| ID: | 2012-0362 |
| Date: | 2019 - Present |
| Title: | A Phase II Pilot Trial To Estimate Survival After A Non-Total Body Irradiation (TBI) Based Conditioning Regimen In Patients Diagnosed With B-Acute Lymphoblastic Leukemia (ALL) Who Are Pre-Allogeneic Hematopoietic Cell Transplantation (HCT) Next-Generation-Sequence (NGS) Minimal Residual Disease (MRD) Negative (PTCTC ONC1701) |
| Funding Source: | NIH/NCI |
| Role: | Collaborator |
| ID: | 2018-0964 |
| Date: | 2018 - Present |
| Title: | Dose Escalation Study Phase 1/11 of Umbilical Cord Blood-Derived CAR-Engineered NK Cells in Conjunction with Lymphodepleting Chemotherapy in Patients with Relapsed/Refractory B-Lymphoid Malignancies |
| Funding Source: | MDACC |
| Role: | Collaborator |
| ID: | 2016-0641 |
| Date: | 2018 - Present |
| Title: | A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) for transplantation in pediatric and adult patients with hematologic malignancies and other indications |
| Funding Source: | CIBMTR |
| Role: | Collaborator |
| ID: | 2011-0541 |
| Date: | 2018 - Present |
| Title: | Managed Access Program (MAP) to provide access to CTL019, for acute lymphoblastic leukemia (ALL) or diffuse large b-cell lymphoma (DLBCL) patients with out of specification leukapheresis product and/or manufactured tisagenlecleucel out of specification for commercial release (Treatment Plan CCTL019B2003I), |
| Funding Source: | Novartis |
| Role: | Collaborator |
| ID: | 2018-0744 |
| Date: | 2018 - Present |
| Title: | Multicenter, open Label, Phase 3 Study of Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Subjects with Epstein-Barr Virus-Associated PostTransplant Lymphoproliferative Disease after Failure of Rituximab or Rituximab and Chemotherapy |
| Funding Source: | ATARA |
| Role: | Collaborator |
| ID: | 2018-0771 |
| Date: | 2018 - Present |
| Title: | A Phase 1/2 Multi-Center Study Evaluating the Safety and Efficacy of KTE-X 19 in Pediatric and Adolescent Subjects with Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia or Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (ZUMA-4) |
| Funding Source: | Kite Pharma |
| Role: | Collaborator |
| ID: | 2016-0316 |
| Date: | 2018 - Present |
| Title: | Phase I study of ex-vivo expanded allogeneic NK cells for the treatment of pediatric solid tumors |
| Funding Source: | MDACC |
| Role: | Collaborator |
| ID: | 2017-0085 |
Selected Publications
Peer-Reviewed Articles
- Frost, M, Okeleji, O, Elgehiny, A, Harrison, DJ, Herzog, CE, Connors, JS, Petropoulos, D, Tewari, P, Ragoonanan, D, Nieto, Y, Sheikh, IN. Gemcitabine, Docetaxel, Melphalan, Carboplatin as Part of Sequential Cycles of High-Dose Chemotherapy With Autologous Hematopoietic Stem-Cell Rescue for Multiply Relapsed/Refractory Pediatric Germ Cell Tumors. Pediatric Blood and Cancer 73(6), 2026. e-Pub 2026. PMID: 41889248.
- Pasvolsky O, Shimony S, Saliba RM, Marcoux C, Ledesma C, Rondon G, Tewari P, Ragoonanan D, Short NJ, Jabbour E, Gooptu M, Ho VT, Soiffer RJ, Antin JH, Koreth J, Cutler CS, Paolino JD, Duncan CN, Lehmann LE, DeAngelo DJ, Jain N, Champlin R, Shpall E, Luskin MR, Kebriaei P. Allogeneic Hematopoietic Stem Cell Transplantation in Adolescents and Young Adults With Acute Lymphoblastic Leukemia-A Retrospective, Dual-Center Study. Am J Hematol 101(1):16-25, 2026. e-Pub 2026. PMID: 41051170.
- Raj R, Catueno S, Gibson A, McCall D, Garcia MB, Nunez C, Roth M, Sasaki K, Tewari P, Issa GC, Farhat A, Connors J, Sheikh I, Nishida Y, Yi JS, Stevens AM, Bataller A, Bhalla K, Petropoulos D, Daver N, Kadia T, Cuglievan B, DiNardo CD. FLAG-IDA plus venetoclax for children, adolescents, and young adults with newly diagnosed AML. Blood 146(21):2608-2611, 2025. e-Pub 2025. PMID: 40971491.
- Fan, AE, Alqahtani, S, Garnes, ND, Tewari, P, Petropoulos, D, Khazal, SJ, Mahadeo, KM, DePriest, P, Sheikh, IN. Bezlotoxumab as Treatment for Recurrent/Chronic Clostridioides difficile Infection in Pediatric Stem Cell Transplant Recipients. Pediatric Blood and Cancer 72(10), 2025. e-Pub 2025. PMID: 40879561.
- He, J, Munir, F, Ayerbe, C, Dickson, S, Catueno, S, Cuglievan, B, Gibson, A, McCall, DC, Nunez, CA, Roth, M, Tewari, P, Garcia, MB, Rodriguez, NI, Cortes, JA. Managing and Preventing Hypofibrinogenemia in Pediatric and AYA Leukemia Patients. Journal of Pediatric Hematology/Oncology 47(5):235-241, 2025. e-Pub 2025. PMID: 40306291.
- Moody KM, Swartz MC, Gresham Z, Askins M, Cahalan L, Geistkemper C, Heaton A, Lin R, Melo M, Rajan A, Smith M, Tewari P, Williams K, Yang CH, Robert R. A Virtual Wellness Program to Enhance Well-being for Pediatric Oncology Staff during the COVID-19 Pandemic. Adv Cancer Educ Qual Improv 1(1), 2025. e-Pub 2025. PMID: 41050054.
- Dennis AA, Colton L, Tewari P, Slavin S. Promoting Well-Being in Graduate Medical Education: Embracing Principles Rather than Recipe. Acad Psychiatry 48(4):378-383, 2024. e-Pub 2023. PMID: 37552402.
- Marcoux, C, Saliba, RM, Wallis, W, Khazal, SJ, Ragoonanan, D, Rondon, G, Tewari, P, Popat, UR, Oran, B, Olson, AL, Bashir, Q, Qazilbash, MH, Alousi, AM, Hosing, C, Nieto, Y, Al-Atrash, G, Marin, D, Rezvani, K, Khouri, IF, Srour, S, Champlin, RE, Shpall, E, Kebriaei, P. Incidence and risk factors of early onset VOD/SOS differ in younger vs older adults after stem cell transplantation. Blood Advances 8(5):1128-1136, 2024. e-Pub 2024. PMID: 38266155.
- Pasvolsky, O, Bassett Jr, R, Ghanem, S, Cuglievan, B, Tewari, P, Hosing, C, Srour, S, Ramdial, JL, Mahadeo, KM, Khazal, SJ, Petropoulos, D, Popat, UR, Qazilbash, MH, Kebriaei, P, Champlin, RE, Shpall, E, Nieto, Y. Characteristics and outcomes of children, adolescents and young adults with relapsed/refractory non-hodgkin lymphoma undergoing autologous stem cell transplant. BMC cancer 23(1), 2023. e-Pub 2023. PMID: 38124057.
- Engler A, Butler B, Tewari P. "The Future Redefined" Pediatric, Adolescent and Young Adult College and Career Fair: A Collaborative Symposium to Provide Proactive Education for Oncology Patients and Survivors. J Adolesc Young Adult Oncol 12(5):787-791, 2023. e-Pub 2023. PMID: 36827457.
- Pasvolsky O, Marcoux C, Milton DR, Tanner MR, Bashir Q, Srour S, Saini N, Lin P, Ramdial J, Nieto Y, Lee HC, Patel KK, Kebriaei P, Tewari P, Crawford-Suber L, Thomas SK, Weber DM, Orlowski RZ, Shpall EJ, Champlin RE, Qazilbash MH. Outcomes of young adults (aged = 40 years) with newly diagnosed multiple myeloma after up-front autologous stem cell transplant. Br J Haematol 202(4):866-873, 2023. e-Pub 2023. PMID: 37376789.
- Nieto Y, Pasvolsky O, Bassett R, Ghanem S, Cuglievan B, Tewari P, Hosing C, Sr S, Ramdial J, Mahadeo K, Khazal S, Petropoulos D, Popat U, Qazilbash M, Kebriaei P, Champlin R, Shpall E. Characteristics and Outcomes of Children, Adolescents and Young Adults with Relapsed/Refractory Non-Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplant. Res Sq, 2023. e-Pub 2023. PMID: 36798261.
- Sheikh IN, Alqahtani S, Ragoonanan D, Tewari P, Petropoulos D, Mahadeo KM, Popat U, Shpall EJ, Khazal S. Post-Transplant Cyclophosphamide after Matched Sibling and Unrelated Donor Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acute Myeloid Leukemia. Int J Mol Sci 23(15), 2022. e-Pub 2022. PMID: 35955881.
- Gardner MK, Amado PJ, Baig MU, Mohiuddin S, Harden A, Ewing LJ, Razvi S, Cortes JA, Mejia R, Petropoulos D, Tewari P, Ahmad AH. Implementing Rounding Checklists in a Pediatric Oncologic Intensive Care Unit. Children (Basel) 9(4), 2022. e-Pub 2022. PMID: 35455624.
- Naik S, Vasileiou S, Tzannou I, Kuvalekar M, Watanabe A, Robertson C, Lapteva N, Tao W, Wu M, Grilley B, Carrum G, Kamble RT, Hill L, Krance RA, Martinez C, Tewari P, Omer B, Gottschalk S, Heslop HE, Brenner MK, Rooney CM, Vera JF, Leen AM, Lulla PD. Donor-derived multiple leukemia antigen-specific T-cell therapy to prevent relapse after transplant in patients with ALL. Blood 139(17):2706-2711, 2022. e-Pub 2022. PMID: 35134127.
- Tambaro FP, Ragoonanan D, Tewari P, Petropoulos D, Aung FM, Mahadeo KM, Khazal S. The Role of Granulocyte Transfusions in Optimizing Candidacy for Chimeric Antigen Receptor T-Cell Therapy in Patients With Treatment-refractory Infections. J Pediatr Hematol Oncol 44(2):E463-E466, 2022. e-Pub 2021. PMID: 33625094.
- Gibson A, Ragoonanan D, Tewari P, Petropoulos D, Rodriguez N, DiNardo C, Mahadeo KM, Khazal S. Non-myeloablative umbilical cord blood transplantation for atypical dyskeratosis congenita. Pediatr Transplant 26(2):e14157, 2022. e-Pub 2022. PMID: 34626046.
- Gaballa MR, Banerjee P, Milton DR, Jiang X, Ganesh C, Khazal S, Nandivada V, Islam S, Kaplan M, Daher M, Basar R, Alousi A, Mehta R, Alatrash G, Khouri I, Oran B, Marin D, Popat U, Olson A, Tewari P, Jain N, Jabbour E, Ravandi F, Kantarjian H, Chen K, Champlin R, Shpall E, Rezvani K, Kebriaei P. Blinatumomab maintenance after allogeneic hematopoietic cell transplantation for B-lineage acute lymphoblastic leukemia. Blood 139(12):1908-1919, 2022. e-Pub 2022. PMID: 34914826.
- Shaw AM, Robert R, Kresta K, Andersen CR, Lewis B, Maetzold B, Valderrama R, Cion I, Tewari P. Totally Excited about Moving Mobility and Exercise (TEAM Me): A Successful Multidisciplinary Exercise Quality Improvement Initiative for Pediatric and Young Adult Oncology and Stem Cell Transplant Inpatients. Children (Basel) 9(2), 2022. e-Pub 2022. PMID: 35204907.
- Ragoonanan D, Bhar S, Mohan G, Beltramo F, Khazal SJ, Hurley C, Andersen C, Margossian S, Neelapu SS, Shpall E, Gutierrez C, Tewari P, Shoberu B, Talleur A, McCall D, Nunez C, Cuglievan B, Tambaro FP, Petropoulos D, Abdel-Azim H, Mahadeo KM. A multicenter study of ICU resource utilization in pediatric, adolescent and young adult patients post CAR-T therapy. Front Oncol 12:1022901, 2022. e-Pub 2022. PMID: 36353531.
- Dahlberg A, Kurtzberg J, Boelens J, Martinez C, Carpenter P, Tewari P, for Transplantation AS, Interest Group CTCBS. Guidelines for Pediatric Unrelated Cord Blood Transplantation-Unique Considerations. Transplant Cell Ther 27(12):968-972, 2021. e-Pub 2021. PMID: 34571212.
- Ragoonanan D, Khazal SJ, Abdel-Azim H, McCall D, Cuglievan B, Tambaro FP, Ahmad AH, Rowan CM, Gutierrez C, Schadler K, Li S, Di Nardo M, Chi L, Gulbis AM, Shoberu B, Mireles ME, McArthur J, Kapoor N, Miller J, Fitzgerald JC, Tewari P, Petropoulos D, Gill JB, Duncan CN, Lehmann LE, Hingorani S, Angelo JR, Swinford RD, Steiner ME, Tejada FNH, Martin PL, Auletta J, Choi SW, Bajwa R, Garnes ND, Kebriaei P, Rezvani K, Wierda WG, Neelapu SS, Shpall EJ, Corbacioglu S, Mahadeo KM. Author Correction: Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer. Nat Rev Clin Oncol. e-Pub 2021. PMID: 33731864.
- Ragoonanan D, Khazal SJ, Wang J, Payne A, Kohorst M, Harden A, Tewari P, Petropoulos D, Shoberu B, Kebriaei P, Mahadeo KM, Tambaro FP. Improved detection of sinusoidal obstructive syndrome using pediatric-AYA diagnostic criteria and severity grading. Bone Marrow Transplant 56(1):175-184, 2021. e-Pub 2021. PMID: 32665674.
- Brown BD, Tambaro FP, Kohorst M, Chi L, Mahadeo KM, Tewari P, Petropoulos D, Slopis JM, Sadighi Z, Khazal S. Immune Effector Cell Associated Neurotoxicity (ICANS) in Pediatric and Young Adult Patients Following Chimeric Antigen Receptor (CAR) T-Cell Therapy: Can We Optimize Early Diagnosis?. Front Oncol 11:634445, 2021. e-Pub 2021. PMID: 33763368.
- Ragoonanan D, Tambaro FP, Khazal SJ, Tewari P, Petropoulos D, Champlin R, Mahadeo KM. Cytokine release syndrome and complete remission of extra medullary acute lymphoblastic leukemia of the breast with CAR-T and radiation therapy. Pediatr Blood Cancer:e28839. e-Pub 2020. PMID: 33258192.
- Kohorst MA, Khazal SJ, Tewari P, Petropoulos D, Mescher B, Wang J, Mahadeo KM, Kelley JM. Transfusion reactions in pediatric and adolescent young adult haematology oncology and immune effector cell patients. EClinicalMedicine 26:100514, 2020. e-Pub 2020. PMID: 32964199.
- Tambaro FP, Khazal S, Nunez C, Ragoonanan D, Tewari P, Petropoulos D, Kebriaei P, Wierda WG, Mahadeo KM. Complete remission in refractory acute lymphoblastic leukemia using blinatumomab after failure of response to CD-19 chimeric antigen receptor T-cell therapy. Clin Case Rep 8(9):1678-1681, 2020. e-Pub 2020. PMID: 32983475.
- Kohorst MA, Nunez CA, Tewari P, Petropoulos D, Mahadeo KM, Neelapu SS, Shpall EJ, Khazal S. Primary mediastinal large B-cell lymphoma in paediatric and adolescent patients: emerging questions in the era of immunotherapy. Br J Haematol 190(2):e114-e117, 2020. e-Pub 2020. PMID: 32469086.
- Harden A, Ragoonanan D, Anildes-Gubman D, McCall D, Faltus K, Featherston S, Shoberu B, Moffet JR, Petropoulos D, Khazal SJ, Razvi S, Mahadeo KM, Tewari P. Chimeric Antigen Receptor, Teamwork, Education, Assessment, and Management (CAR-TEAM): A Simulation-Based Inter-professional Education (IPE) Intervention for Management of CAR Toxicities. Front Oncol 10:1227, 2020. e-Pub 2020. PMID: 32850365.
- Im JS, Abraham SC, Saliba RM, Rondon G, Ross WA, Rashid A, Shpall EJ, Popat U, Qazilbash MH, Hosing C, Oran B, Shah N, Tewari P, Nieto Y, Kebriaei P, Champlin RE, Alousi AM. Histologic Grade 1 Is Associated With Increased Nonrelapsed Mortality in Lower Gastrointestinal Graft Versus Host Disease. Am J Surg Pathol 41(11):1483-1490, 2017. e-Pub 2017. PMID: 28834808.
- Maher OM, Silva JG, Huh WW, Cuglievan B, DePombo A, Kebriaei P, Park M, Liu D, Tillman C, Tarek N, Cooper LJN, Tewari P. Etiologies and Impact of Readmission Rates in the First 180 Days After Hematopoietic Stem Cell Transplantation in Children, Adolescents, and Young Adults. J Pediatr Hematol Oncol 39(8):609-613, 2017. e-Pub 2017. PMID: 28859043.
- Galvez-Silva J, Maher OM, Park M, Liu D, Hernandez F, Tewari P, Nieto Y. Prognostic Analysis of Absolute Lymphocyte and Monocyte Counts after Autologous Stem Cell Transplantation in Children, Adolescents, and Young Adults with Refractory or Relapsed Hodgkin Lymphoma. Biol Blood Marrow Transplant 23(8):1276-1281, 2017. e-Pub 2017. PMID: 28435146.
- Maher OM, Silva JG, Wu J, Liu D, Cooper LJ, Tarek N, Worth L, Lee DA, Petropoulos D, Franklin AR, Zweidler-Mckay P, Wells RJ, Rondon G, Champlin RE, Tewari P. Outcomes of children, adolescents, and young adults following allogeneic stem cell transplantation for secondary acute myeloid leukemia and myelodysplastic syndromes-The MD Anderson Cancer Center experience. Pediatr Transplant 21(3), 2017. e-Pub 2017. PMID: 28160352.
- Mahadeo KM, Tewari P Parikh SH, Driscoll TA, Page K, Martin PL, Kurtzberg J, Prasad VK. Durable engraftment and correction of hematological abnormalities in children with congenital amegakaryocytic thrombocytopenia following myeloablative umbilical cord blood transplantation. Pediatr Transplant 19(7):753-7, 2015. e-Pub 2015. PMID: 26369627.
- Popat U, Mehta RS, Rezvani K, Fox P, Kondo K, Marin D, McNiece I, Oran B, Hosing C, Olson A, Parmar S, Shah N, Andreeff M, Kebriaei P, Kaur I, Yvon E, de Lima M, Cooper LJ, Tewari P, Champlin RE, Nieto Y, Andersson BS, Alousi A, Jones RB, Qazilbash MH, Bashir Q, Ciurea S, Ahmed S, Anderlini P, Bosque D, Bollard C, Molldrem JJ, Chen J, Rondon G, Thomas M, Miller L, Wolpe S, Simmons P, Robinson S, Zweidler-McKay PA, Shpall EJ. Enforced fucosylation of cord blood hematopoietic cells accelerates neutrophil and platelet engraftment after transplantation. Blood 125(19):2885-92, 2015. e-Pub 2015. PMID: 25778529.
- Abdel-Azim H, Balian C, Tewari P, Santizo R, Kapoor N, Mahadeo KM. A survey of infectious disease clinical practices among pediatric blood and marrow transplant programs in the United States. Pediatr Blood Cancer 62(4):731-5, 2015. e-Pub 2015. PMID: 25557155.
- Kumaresan P, Figliola M, Moyes JS, Huls MH, Tewari P, Shpall EJ, Champlin R, Cooper LJ. Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System. J Vis Exp(104), 2015. e-Pub 2015. PMID: 26484782.
- Mehta RS, Di Stasi A, Andersson BS, Nieto Y, Jones R, de Lima M, Hosing C, Popat U, Kebriaei P, Oran B, Alousi A, Rezvani K, Qazilbash M, Bashir Q, Bollard C, Cooper L, Worth L, Tewari P, McNiece I, Willhelm K, Champlin R, Shpall EJ. The Development of a Myeloablative, Reduced-Toxicity, Conditioning Regimen for Cord Blood Transplantation. Clin Lymphoma Myeloma Leuk 14(1):e1-5, 2014. e-Pub 2014. PMID: 24169268.
- Tewari P, Martin PL, Mendizabal A, Parikh SH, Page KM, Driscoll TA, Malech HL, Kurtzberg J, Prasad VK. Myeloablative transplantation using either cord blood or bone marrow leads to immune recovery, high long-term donor chimerism and excellent survival in chronic granulomatous disease. Biol Blood Marrow Transplant 18(9):1368-77, 2012. e-Pub 2012. PMID: 22326631.
Invited Articles
- Tewari, P. Workforce & Training Perspective: Evaluation and Evolution of the Pediatric Hematology-Oncology Fellowship Recruitment Process. American Academy of Pediatrics Section on Hematology/Oncology Newsletter, 2022. e-Pub 2022.
- Tewari P, Wallis W, Kebriaei P. Manifestations and management of veno-occlusive disease/sinusoidal obstruction syndrome in the era of contemporary therapies. Clin Adv Hematol Oncol 15(2):130-139, 2017. e-Pub 2017. PMID: 28398284.
- Tewari P, Franklin AR, Tarek N, Askins MA, Mofield S, Kebriaei P. Hematopoietic stem cell transplantation in adolescents and young adults. Acta Haematol 132(3-4):313-25, 2014. e-Pub 2014. PMID: 25228557.
Review Articles
- McCall, DC, Catueno, S, Ramakrishnan, R, Tewari, P, Sheikh, IN, Gibson, A, Nunez, CA, Garcia, MB, Cuglievan, B. Beyond Cellular Therapies. Acta haematologica 149(1):84-100, 2026. e-Pub 2026. PMID: 40324358.
- Fan, AE, Vasconez, WA, Ramakrishnan, R, Tewari, P, Olson, AL, Shpall, E, Sheikh, IN. Post-Transplant Cyclophosphamide for Graft-Versus-Host Disease Prophylaxis in Pediatric Stem Cell Transplantation. Pediatric Blood and Cancer 72(12), 2025. e-Pub 2025. PMID: 40985530.
- Cuglievan, B, Kantarjian, HM, Rubnitz, JE, Cooper, T, Zwaan, CM, Pollard, J, DiNardo, C, Kadia, TM, Guest, E, Short, NJ, McCall, DC, Daver, N, Nunez, CA, Haddad, FG, Garcia, MB, Bhalla, K, Maiti, A, Catueno, S, Fiskus, WC, Carter, BZ, Gibson, A, Roth, M, Khazal, SJ, Tewari, P, Abbas, HA, Bourgeois, W, Andreeff, M, Shukla, N, Truong, D, Connors, JS, Ludwig, JA, Stutterheim, J, Salzer, E, Juul-Dam, KL, Sasaki, K, Mahadeo, KM, Tasian, SK, Borthakur, G, Dickson, S, Jain, N, Jabbour, EJ, Meshinchi, S, Garcia-Manero, G, Ravandi, F, Stein, EM, Kolb, EA, Issa, GC. Menin inhibitors in pediatric acute leukemia. Leukemia 38(10):2073-2084, 2024. e-Pub 2024. PMID: 39179671.
- He, J, Munir, F, Catueno, S, Connors, JS, Gibson, A, Robusto, L, McCall, DC, Nunez, CA, Roth, M, Tewari, P, Garces, S, Cuglievan, B, Garcia, MB. Biological Markers of High-Risk Childhood Acute Lymphoblastic Leukemia. Cancers 16(5), 2024. e-Pub 2024. PMID: 38473221.
- Cuglievan B, Connors J, He J, Khazal S, Yedururi S, Dai J, Garces S, Quesada AE, Roth M, Garcia M, McCall D, Gibson A, Ragoonanan D, Petropoulos D, Tewari P, Nunez C, Mahadeo KM, Tasian SK, Lamble AJ, Pawlowska A, Hammond D, Maiti A, Haddad FG, Senapati J, Daver N, Gangat N, Konopleva M, Meshinchi S, Pemmaraju N. Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapies. Leukemia 37(9):1767-1778, 2023. e-Pub 2023. PMID: 37452102.
- Munir F, Hardit V, Sheikh IN, AlQahtani S, He J, Cuglievan B, Hosing C, Tewari P, Khazal S. Classical Hodgkin Lymphoma: From Past to Future-A Comprehensive Review of Pathophysiology and Therapeutic Advances. Int J Mol Sci 24(12), 2023. e-Pub 2023. PMID: 37373245.
- He, J, Munir, F, Ragoonanan, D, Zaky, W, Khazal, SJ, Tewari, P, Fueyo-Margareto, J, Gomez-Manzano, C, Jiang, H. Combining CAR T Cell Therapy and Oncolytic Virotherapy for Pediatric Solid Tumors. Immuno 3(1):37-56, 2023. e-Pub 2023.
- Munir F, He J, Connors J, Garcia M, Gibson A, McCall D, Nunez C, Dinh CN, Robusto L, Roth M, Khazal S, Tewari P, Cuglievan B. Translational advances in the treatment of childhood acute lymphoblastic leukemia: narrative review of current and emerging molecular and immunotherapies. Transl Pediatr 12(3):487-502, 2023. e-Pub 2023. PMID: 37035397.
- Ragoonanan D, Sheikh IN, Gupta S, Khazal SJ, Tewari P, Petropoulos D, Li S, Mahadeo KM. The Evolution of Chimeric Antigen Receptor T-Cell Therapy in Children, Adolescents and Young Adults with Acute Lymphoblastic Leukemia. Biomedicines 10(9), 2022. e-Pub 2022. PMID: 36140387.
- Sheikh IN, Ragoonanan D, Franklin A, Srinivasan C, Zhao B, Petropoulos D, Mahadeo KM, Tewari P, Khazal SJ. Cardiac Relapse of Acute Lymphoblastic Leukemia Following Hematopoietic Stem Cell Transplantation: A Case Report and Review of Literature. Cancers (Basel) 13(22), 2021. e-Pub 2021. PMID: 34830969.
- Ragoonanan D, Khazal SJ, Abdel-Azim H, McCall D, Cuglievan B, Tambaro FP, Ahmad AH, Rowan CM, Gutierrez C, Schadler K, Li S, Di Nardo M, Chi L, Gulbis AM, Shoberu B, Mireles ME, McArthur J, Kapoor N, Miller J, Fitzgerald JC, Tewari P, Petropoulos D, Gill JB, Duncan CN, Lehmann LE, Hingorani S, Angelo JR, Swinford RD, Steiner ME, Hernandez Tejada FN, Martin PL, Auletta J, Choi SW, Bajwa R, Dailey Garnes N, Kebriaei P, Rezvani K, Wierda WG, Neelapu SS, Shpall EJ, Corbacioglu S, Mahadeo KM. Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer. Nat Rev Clin Oncol. e-Pub 2021. PMID: 33608690.
- Ragoonanan D, Khazal SJ, Mejia R, Ewing L, Durand JB, Bashoura L, Tayar J, Dailey Garnes N, Petropoulos D, Tewari P, Bhatti M, Ahmad AH, Cortes J, Razvi S, McBeth K, Swinford R, Shoberu B, Waseemuddin W, Chi L, Gill JB, Zaky W, Daw N, Gutierrez C, Tereffe W, Kebriaei P, Rezvani K, Shpall EJ, Champlin RE, Mahadeo KM. Case Discussion and Literature Review: Cancer Immunotherapy, Severe Immune-Related Adverse Events, Multi-Inflammatory Syndrome, and Severe Acute Respiratory Syndrome Coronavirus 2. Front Oncol 11:625707, 2021. e-Pub 2021. PMID: 33614514.
- Mahadeo KM, Bajwa R, Abdel-Azim H, Lehmann LE, Duncan C, Zantek N, Vittorio J, Angelo J, McArthur J, Schadler K, Chan S, Tewari P, Khazal S, Auletta JJ, Choi SW, Shoberu B, Kalwak K, Harden A, Kebriaei P, Abe JI, Li S, Moffet JR, Abraham S, Tambaro FP, Kleinschmidt K, Richardson PG, Corbacioglu S, Lung Injury PA, (PALISI) Network SI, for Blood TPDWPOTES, Transplantation M. Diagnosis, grading, and treatment recommendations for children, adolescents, and young adults with sinusoidal obstructive syndrome: an international expert position statement. Lancet Haematol 7(1):e61-e72, 2020. e-Pub 2020. PMID: 31818728.
- Mahadeo KM, Khazal SJ, Abdel-Azim H, Fitzgerald JC, Taraseviciute A, Bollard CM, Tewari P, Duncan C, Traube C, McCall D, Steiner ME, Cheifetz IM, Lehmann LE, Mejia R, Slopis JM, Bajwa R, Kebriaei P, Martin PL, Moffet J, McArthur J, Petropoulos D, O'Hanlon Curry J, Featherston S, Foglesong J, Shoberu B, Gulbis A, Mireles ME, Hafemeister L, Nguyen C, Kapoor N, Rezvani K, Neelapu SS, Shpall EJ, Lung Injury PA, (PALISI) Network SI. Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy. Nat Rev Clin Oncol 16(1):45-63, 2019. e-Pub 2019. PMID: 30082906.
Professional Educational Materials
- . Contemporary Critical Care Complications of SCT/Cellular Therapies, 2021.
- . VIRTI Software Simulation for Evidence-Based Management of Sinusoidal Obstruction Syndrome, 2021.
- . VIRTI Software Simulation for Car-T Toxicity Management, 2021.
Editorials
- Okeleji, O, McCall, DC, Gibson, A, Garcia, MB, Nunez, CA, Roth, M, Connors, JS, Petropoulos, D, Tewari, P, Cuglievan, B, Sheikh, IN. Post transplant maintenance therapy with newly FDA-approved revumenib for high-risk KMT2Ar acute leukemia. Blood Advances 9(8):1988-1990, 2025. PMID: 39993239.
Abstracts
- Livingston J, Ragoonanan D, Tewari P, Gill JB, Banck S, Gao M, Lin HY, Li Y, Xia X, Hu J, Jin Y, Shpall EJ, Kaur I, Asfaw T, Alvarez F, Wang W, Somaiah N, Patel S, Gorlick RG, Li S. A first-in-human phase 1 trial of T cell membrane-anchored tumor targeted IL12 (ATTIL12) -T cell therapy in advanced/metastatic soft tissue and bone sarcoma. 2024 ASCO Annual Meeting, 2024. e-Pub 2024.
- He J, Munir F, Ayerbe C, Dickson S, Catueno S, Garcia M, Gibson A, McCall D, Nunez C, Roth M, Tewari, P, Cuglievan B, Cortes J. Management of Acquired Hypofibrinogenemia In Children with Leukemoa. 2024 ASPHO Conference - Poster, 2024. e-Pub 2024.
- Connors J, Saliba R, Ledesma C, Garris R, Tewari P, Kebriaei P. Single Center Evaluation of Patients with Therapy and Prior-Malignancy Related Acute Lymphoblastic Leukemia and the Use of Hematopoietic Stem Cell Transplants. Tandem Meeting, 2024. e-Pub 2024.
- Tewari, P. Allogeneic Hematopoietic Stem Cell Transplantation in Adolescents and Young Adults with Acute Lymphoblastic Leukemia – Retrospective Dual-Center Study. ASH Annual Meeting, 2023. e-Pub 2023.
- Afridi, F Idemmilli F, R Gresham R, Z Swartz Z, M Tewari M, P Sandoval P, M Williams M, K, Askins, M Rajan M, A Lin A, R Yan R, C Robert C, R Moody R, K. An Interprofessional Virtual Program to Strengthen Team Cohesion. 26th Supportive & Palliative Care Clinical and Research Symposium, Virtual, 2023. e-Pub 2023.
- Idemmilli, R Afridi R, F Gresham F, Z Swartz Z, M Tewari M, P Sandoval P, M Williams M, K, Askins, M Rajan M, A Lin A, R Yan R, C Robert C, R Moody R, K. An Interprofessional Virtual Program to Strengthen Team Cohesion. American Society of Pediatric Hematology Oncology, 2023. e-Pub 2023.
- Gibson, A Moore A, J, Tewari, P. Creation and Implementation of an Active Board Prep Electronic Platform using Qualtrics Survey Software to Integrate and Enhance Pediatric Hematology-Oncology Fellow Board Exam Preparation and Improve Perception of Learner Board Preparation. Association of Pediatric Program Directors, 2022. e-Pub 2022.
- Gibson, A Moore A, J, Tewari, P. Creation and Implementation of an Active Board Prep Electronic Platform using Qualtrics Survey Software to Integrate and Enhance Pediatric Hematology-Oncology Fellow Board Exam Preparation and Improve Perception of Learner Board Preparation. UT Advances in Teaching and Learning, 2021. e-Pub 2021.
- Berrios, Jasmin, Cavalier, James, Mahadeo, Kris, Tewari, Priti, MD, Anildes-Gumban, Daryl, Bodurka, Diane. Virtual Reality Technology: Driving Innovation in Healthcare Education and Training, UT MD Anderson Education Week Showcase and Poster Presentation, 2021. e-Pub 2021.
- Ragoonanan D, Brown A, Khazal SJ, Tewari P, Petropoulos D, Than K, Shoberu B, Ogwo V, Williams L, Gutierrez C, Mahadeo KM. ICU Resource Utilization In Pediatric And Adolescent Young Adult Patients Post Car-T Therapy. 47th Annual Meeting of the European Society for Blood and Marrow Transplantation, 2021. e-Pub 2021.
- Gibson, A Moore A, J, Tewari, P. Creation and Implementation of an Active Board Prep Electronic Platform using Qualtrics Survey Software to Integrate and Enhance Pediatric Hematology-Oncology Fellow Board Exam Preparation and Improve Perception of Learner Board Preparation. UT Shine Innovations in Health Science Education, 2021. e-Pub 2021.
- Harden A, Ragoonanan D, Tambaro P, Mahadeo K, Tewari P. Oral Presentation: Education for the Clinical Implementation of CAR-T Cell Therapy using Simulation Based Education for Evidence Based Management of Chimeric Antigen Receptor T-cell Related Cytokine Release Syndrome and Encephalopathy Syndrome. EBMT, 2nd European CAR T Cell, 2020. e-Pub 2020.
- Kohorst M, Mahadeo K, Khazal S, Tewari P, Petropoulos D, Mescher B, Kelly J. Improving recognition and Reporting of Transfusion Reactions in Pediatric and Young Adult Stem Cell Transplant and Oncology Patients. American Society for Transplantation and Cellular Therapy, 2020. e-Pub 2020.
- Ragoonanan D, Anildes-Gumban D, Mohiuddin, Angelo, JA, Mahadeo, KM, Razvi S, Tewari P. The Efficacy of Simulation Based Education for the Evidenced Based Management of Veno-Occlusive Disease. 6th Annual BCM Quality Improvement and Patient Safety, 2019. e-Pub 2019.
- Beaver B, John T, Craddock J, Krance R, Tewari P. The Effectiveness of Neutropenic Diet in Pediatric Stem Cell Transplant Recipients. American Society of Blood and Marrow Transplantation, 2019. e-Pub 2019.
- Harden A, Ragoonanan D, Featherston SK, McCall D, Faltus K, Anildes-Gumban D, Khazal S, Shoberu B, Mahadeo KM, Razvi S, Tambaro FP, Tewari P. Simulation Based Education For the Evidenced Based Management of Chimeric Antigen Receptor T-Cell Related Encephalopathy Syndrome and Cytokine Release Syndrome. American Society of Pediatric Hematology/Oncology, 2019. e-Pub 2019.
- Tewari P, Lewis B, Kresta K, Shaw A, Robert R, Maetzold B, Valderrama R, Harman N, Cion I, Franklin Q, Morse E, Skillman D, Schwartz D. Totally Excited about Moving Mobility, and Exercise (TEAM Me): Multidisciplinary Effort to Help Increase Mobility for Children, Adolescents and Young Adults during their Inpatient Admission. ASPHO (American Society of Pediatric Hematology/Oncology), 2016. e-Pub 2016.
- Tewari P, Ahlstrom K, Cuglievan B, Craven P, Gatliff M, Shepard C. Poster Presentation: Implementation of Parameter Transfusion orders for Stem Cell Transplant Recipients Results in Increased Nursing Autonomy, Decreased Transfusion Delays, and Improved Patient Care. ASPHO (The American Society of Pediatric Hematology/Oncology), 2016. e-Pub 2016.
- Tewari P, Lewis B, Kresta K, Shaw A, Robert R, Maetzold B, Valderrama R, Harman N, Cion I, Franklin Q, Morse E, Skillman D, Schwartz C. Oral Presentation: Totally Excited about Moving, Mobility, and Exercise (TEAM Me): Multidisciplinary Effort to Help Increase Mobility of children, Adolescents and Young Adults During Their Inpatient Admission. ASPHO (The American Society of Pediatric Hematology/Oncology), 2016. e-Pub 2016.
- Silva JG, Maher O, Park M, Liu D, Tewari P, Hernandez F, Nieto Y. Poster Presentation: Analysis of the Prognostic Effect of Peripheral Blood Lymphocyte and Monocyte Count after Autologous Hematopoietic Stem Cell Transplant in Refractory/Relapsed Hodgkin's Lymphoma in a Pediatric, Adolescent, and Young Adult Population. ASBMT/BMT Tandem, 2016. e-Pub 2016.
- Maher O, Silva JG, Tillman C, Petropoulos D, Cooper LJN, Lee D, Worth LL, Champlin RE, Tarek N, Tewari P. Poster Presentation: Incidence and Outcome of Early Hospital Readmission Following Hematopoetic Stem Cell Transplantation in Pediatric and Young Adult Patients. Biol Blood Marrow Transplant 21(2 Suppl):S249, 2015. e-Pub 2015. PMID: 25534537.
- Schneider V, Sung K, Christensen A, Szewczyk N, Dela Cruz B, Kresta K, Tewari P. Implementation of Parameter Transfusion Orders for Stem Cell Transplant Recipients Results in Increased Nursing Anatomy, Decreased Transfusion Delays, and Improved Patient Care. Biology of Blood and Marrow Transplantation 20(2):S285, 2014. e-Pub 2014.
- Tewari P, Kumaresan P, Figliola M, Huls H, Longin K, Ruhnke K, Champlin R, Cooper J. Poster Presentation: Automated Production of Clinical-Grade CMV-Specific T Cells to Implement Immunotherapy at the Bedside. Biology of Blood and Marrow Transplantation 20(2):S136-S137, 2014. e-Pub 2014.
- Prasad VK, Mendizabal A, Tewari P, Page K, Parikh SH, Szabolcs P, Driscoll TA, Martin PL, Kurtzberg J. Oral Presentation: Differential impact of HLA-A, -B, and -DRB1 mismatching in relation to other variables on the outcomes of myeloablative unrelated single donor umbilical cord blood transplantation from 4/6 matched units in children and young adults. Biology of Blood and Marrow Transplantation 17(2 (Suppl)):S185-S186, 2011. e-Pub 2011.
- Desai SR, Tewari P, Whelan M, Kurtzberg J, Prasad VK. Poster Presentation: Vitamin D deficiency in children undergoing hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation 17(2 (Suppl)):S274, 2011. e-Pub 2011.
- Tewari P, Allison J, Waters-Pick B, Cash JV, Kurtzberg J, Prasad VK. Poster Presentation: Collection of G-CSF-mobilized granulocytes from related donors to support hematopoietic stem cell transplant recipients at high risk of infection is safe and feasible. Biology of Blood and Marrow Transplantation 17(2 (suppl)):S272, 2011. e-Pub 2011.
- Tewari P, Martin PL, Parikh SH, Szabolcs P, Page KM, Driscoll TA, Kurzburg J, Prasad VK. Oral Presentation: Correction of immune defect, excellent survival, and long-term donor chimerism in children with chronic granulomatous disease after myeloablative transplantation across donor and graft sources. Biology of Blood and Marrow Transplantation 16(2 (Suppl)):S185, 2010. e-Pub 2010.
- Tewari P, Wood S, Martin PL, Parikh SH, Szaboics P, Page KM, Discoll T, Kurtzberg J, Prasad VK. Poster Presentation: Transplantation following myeloablative cytoreduction results in excellent survival, long-term engraftment, and donor chimerism in children with chronic granulomatous disease across donor and graft sources. Blood 114(22):3398 - 3398, 2009. e-Pub 2009.
Book Chapters
- Tewari P, Bajwa R, Taraseviciute A, Moffet J, McCall D, Mahadeo K. In: Hematopoietic Stem Cell Transplant and Cellular Therapy, in Critical Care of the Pediatric Immunocompromised Hematology/Oncology Patient, 2019.
Books (edited and written)
- Tewari P, Nash A. Pediatric Hematology-Oncology Rapid Review Flash Cards Print + eBook with Multimedia. Ed(s) 1, 2026.
Letters to the Editor
- Okeleji, O, McCall, DC, Cuglievan, B, Gibson, A, Petropoulos, D, Tewari, P, Connors, JS, Sheikh, IN. Immune-related toxicity profile after haematopoietic stem cell transplantation in patients with B-ALL given combination immunotherapy with rituximab, inotuzumab and blinatumomab. British Journal of Haematology 208: 1462-1466, 2026.
- Sheikh, IN, Alqahtani, S, Okeleji, O, Brown, BD, Ragoonanan, D, Waseemuddin, M, Shoberu, B, Kawedia, J, Khazal, SJ, Connors, JS, Petropoulos, D, Tewari, P, Bonfim, C, Driscoll, TA, DePriest, BP, Mahadeo, KM. Pre-transplant immunosuppression in pediatric patients undergoing haploidentical stem cell transplant for sickle cell disease is associated with positive outcomes. Bone marrow transplantation 61: 241-244, 2026.
- Cohen, E, Okeleji, O, McCall, DC, Garcia, MB, Nunez, CA, Cuglievan, B, Herzog, CE, Razvi, S, Tewari, P, Douglas, H, Gibson, A. Synchronous Mediastinal Germ Cell Tumor with Sarcomatous Transformation and Acute Myeloid Leukemia. Pediatric Blood and Cancer 72, 2025.
- Okeleji, O, Khazal, SJ, Mahadeo, KM, Ragoonanan, D, Rodriguez, NI, DiNardo, C, Connors, JS, Petropoulos, D, Tewari, P, Sheikh, IN. Allogeneic Hematopoietic Stem Cell Transplant for an Unknown Inherited Bone Marrow Failure Syndrome With a Novel Compound Heterozygous Mutation. Pediatric Blood and Cancer 72, 2025.
- Rafaeli, N, Costa, DM, Ledesma, C, Jain, N, Tewari, P, Khouri, IF, Al-Atrash, G, Short, NJ, Jabbour, EJ, Rezvani, K, Alousi, AM, Popat, UR, Champlin, RE, Shpall, E, Kebriaei, P. Allogeneic Hematopoietic Stem Cell Transplantation Following CAR T Therapy in Relapsed/Refractory Acute Lymphoblastic Leukemia. Clinical Lymphoma, Myeloma and Leukemia 25: e374-e377, 2025.
- Sheikh, IN, Uwaezuoke, D, Okeleji, O, Quesada, AE, Herzog, CE, Ragoonanan, D, Tewari, P, Petropoulos, D, McCall, DC, Nunez, CA, Roth, M, Cuglievan, B, Khazal, SJ. Treatment of a Pediatric Patient with Core Binding Factor Acute Myeloid Leukemia Post-Cytotoxic Therapy With Cytarabine, Daunorubicin, and Gemtuzumab Followed by Stem Cell Transplantation. Pediatric Blood and Cancer 72, 2025.
- Gibson A, Nunez C, Robusto L, Kammerer B, Garcia M, Roth M, Sheth R, Tewari P, Hittle A, Toepfer L, Torres R, Short NJ, Jabbour E, Jain N, Cuglievan B, McCall D. Combination low-intensity chemotherapy plus inotuzumab ozogamicin, blinatumomab and rituximab for pediatric patients with relapsed/refractory B-cell acute lymphoblastic leukemia. Haematologica 109: 3042-3047, 2024.
- McCall D, Tewari P, Kass JDA, Cuglievan B. The Evolution of the Pediatric Hematology/Oncology Fellowship: What Does it Mean to be Productive?. J Pediatr Hematol Oncol 42: e544-e545, 2020.
Patient Reviews
CV information above last modified July 22, 2026